Search

Search Results
Results 1171 - 1180 of 1449 for chronic pain syndrome
  • News - 19 Jan 2009
    Forest Laboratories, Inc. and Cypress Bioscience, Inc. have announced that Savella (milnacipran HCl), a selective serotonin and norepinephrine dual reuptake inhibitor, was approved by the U.S. Food...
  • News - 8 Dec 2008
    A study assessing the quality of care for patients with sickle cell disease in a variety of hospital settings was presented Saturday, December 6 during the 50th Annual Meeting of the American Society...
  • News - 5 Sep 2007
    Jennifer Sieck knew something had to be done when she would lie in bed most of the day and night.
  • News - 17 May 2007
    The study was categorized as a primary prevention trial for coronary heart disease, although the fact that mean age at recruitment was 63 years was not given enough importance at that time. WHI...
  • News - 6 Dec 2004
    Excruciating pain episodes, recurrent pneumonias, strokes, severe infections, chronic hemolytic anemia, and secondary pulmonary hypertension are common complications of sickle cell disease, a...
  • News - 2 Nov 2004
    Scientists are now uncovering increasing evidence that the brain not only responds to hormones produced by the reproductive system, but that these hormones-the so-called "female hormones," estrogen...
  • Drug - 24 Feb 2025
    Consumer Medicine Information (CMI) about Brenda-35 ED intended for persons living in Australia.
  • Drug - 26 Sep 2024
    Consumer Medicine Information (CMI) about Xolair intended for persons living in Australia.
  • Health - 25 Mar 2024
    Lupus is a chronic inflammatory autoimmune disorder. This article describes several methods used to diagnose the different types of lupus.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Minulet intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.